GLP-1s work well for diabetes, obesity and related conditions, but they carry side effects. The Conversation lays out what users should know.
Recap by typeshit. Post by The Conversation - Australia + New Zealand on X.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
Mubadala Bio's Hamad Almarzooqi says the drugs will be contract-manufactured in the UAE and shipped across the region and beyond. He announced it at the Abu Dhabi Future Health Summit.
19:01
Part three of their series looks at choosing between brand-name Zepbound and compounded tirzepatide, drawing on their own experience so far.
Loading…